ArticleLung Cancer (Auckland, N.Z.)2024

Effectiveness and Safety of Anlotinib Combined with PD-1 Blockades in Patients with Previously Immunotherapy Treated Advanced Non-Small Cell Lung Cancer: A Retrospective Exploratory Study.

Xue-Jun Dou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.